Home / Companies / Apogee Therapeutics, Inc. / 5 Jun 2024
Apogee Therapeutics, Inc.: meeting of 5 Jun 2024
Votes reported on Form N-PX, item by item
107 Form N-PX filers reported votes at the Apogee Therapeutics, Inc. meeting of 5 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 58.8% of reported votes for; 50 filers withheld from or voted against at least one nominee.
594 vote records from 107 filers. 45 of the 105 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
198 vote records from 107 filers. 1 of the 105 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
198 vote records from 107 filers. 6 of the 105 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| State Street and SPDR | Abstain or withhold * | For |
| American Century | Abstain or withhold * | For |
| Franklin Templeton | Abstain or withhold * | For |
| Invesco | For | For |
| Equitable | For | For |
| Charles Schwab | Abstain or withhold * | For |
| Nuveen and TIAA | For | For |
| ProShares and ProFunds | Abstain or withhold * | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For |
| Goldman Sachs | Abstain or withhold * | For |
| PGIM and Prudential | Abstain or withhold * | For |
| Jackson National funds | Abstain or withhold * | For |
| Northern Trust and FlexShares | Abstain or withhold * | For |
| SEI | Abstain or withhold * | For |
| T. Rowe Price | For | For |
| Lincoln Financial | Abstain or withhold * | For |
| Voya | For | For |
| First Trust | Abstain or withhold * | For |
| Nationwide | Abstain or withhold * | For |
| Victory Capital | Abstain or withhold * | For |
| Brighthouse Funds | Abstain or withhold * | For |
| Guggenheim and Rydex | Abstain or withhold * | For |
| BNY Mellon | For | For |
| Principal | For | For |
| Pacific Life funds | For | For |
| Global X | Abstain or withhold * | For |
| AllianceBernstein | For | For |
| Hartford Funds | For | For |
| DWS | Abstain or withhold * | For |
| MassMutual | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Apogee Therapeutics, Inc. meeting?
107 Form N-PX filers reported votes at the meeting of 5 Jun 2024. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Apogee Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Apogee Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Apogee Therapeutics, Inc. with a meeting date within three days of 5 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.